Home » Biotechnology » Sepsis Diagnostics Market

Sepsis Diagnostics Market By Product (Blood Culture Media, Assay Kits And Reagents, Instruments), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry) – Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Summary
Table Of Content

Market Insights

Sepsis patients present with several symptoms, ranging from tremors and fever to severe confusion. However, the most critical indication of sepsis is a sudden and significant drop in blood pressure, leading to an incidence of septic shock and consequent organ failure. Sepsis is one of the prime causes of in-hospital mortality and also ranks among the most cost-intensive conditions being treated in hospitals worldwide.

Despite its enormous prevalence, sepsis treatment remains an object of speculation in several ways. Sepsis is termed a syndrome and not a single disease, thus exhibiting a collection of several causes and effects on patients. As the clinical understanding of sepsis advances, the definition and diagnosis methods of sepsis are also correspondingly changing. Furthermore, because it is an expensive condition to treat, healthcare providers worldwide are emphasizing the earliest detection of sepsis and the establishment of a standard guideline for intervention.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

The scope this report on the sepsis diagnostics market offers a detailed analysis of the market based on diagnosis products, technologies, and geographical segmentation. Based on product types, the global sepsis diagnostics market is studied for blood culture media, assay kits, reagents, and instruments. Molecular diagnostics, microbiology, immunoassays, and flow cytometry are the technologies that are employed for the efficient diagnosis of sepsis. Each of the above-mentioned segments is studied in terms of the latest prevalent market trends, along with its market size and forecast for the period from 2015 to 2025. In addition, the CAGRs of these segments for the forecast period 2017–2025 are also included in this study.

Based on the geographical demarcation of the globe, the sepsis diagnostics market is studied for North America (comprising the United States and Canada), Europe (studied for the United Kingdom, Germany, and the rest of Europe), Asia Pacific (cumulative to China, Japan, and the rest of Asia Pacific), Latin America (including Brazil, Mexico, and the rest of Latin America), and the Middle East and Africa (the GCC and the rest of Europe). For the time period under consideration, market size and forecast are also provided for each regional and country-level market.

This report also analyses the global market from the perspective of currently prevalent drivers and restraining factors. Future opportunities to be harnessed are also discussed in this study. The report also studied the competitive landscape of the major market players for the year 2016. An attractive investment proposition is also presented in this study to suggest the most prominent regional market eligible for proliferation, focus, and corresponding investment. This report concludes with profiles of major players enjoying prominent positions in the global sepsis diagnostics market.

Based on product types, the global sepsis diagnostics market is segmented as follows:

Blood Culture Media
assay kits and reagents
Instruments

Sepsis is one of the most common causes of death in hospitals. It is projected that the sepsis diagnostics market will show prominent market growth during the forecast period due to significant growth in the number of sepsis patients emerging from a rise in the number of surgeries, hospital-acquired infections, and technological advancements in sepsis management. Early detection is eminently needed for the improved outcome of treatment for patients affected by sepsis. Blood culture media have been known to be the largest revenue-contributing segment in recent years because they remain the gold standard detection method in the microbiological diagnosis of sepsis due to their sensitivity and specificity. A number of advancements have been made in blood culture media, such as developments in enriched growth media, software for faster detection, etc. Despite these technological advancements, blood culture remains a time-consuming method. Moreover, the risk of false negative results due to the inhibitory effects of fastidious pathogens and antibiotics also limits the use of blood culture media.

It is anticipated that assay kits will show lucrative market growth during the forecast period due to rising adoption, a faster detection method, and growing approval for assay kits. Although there are a number of manufacturers present in the market, the assay kits and reagent market is currently dominated by Thermo Fisher Scientific, Roche Diagnostics, T2 Biosystems, Bruker Corporation, etc.

Based on technology type, the global sepsis diagnostics market is segmented as follows:

Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry

Despite the advancement in the healthcare system, mortality related to sepsis remains high; an accurate diagnosis is significant for the correct identification of sepsis-causing pathogens. At present, molecular diagnostic techniques are emerging, and it is expected to show the highest market growth over the forecast period as it is a more rapid and accurate process than the conventional method. Previously, microbiology detection techniques were widely accepted, but due to increased time consumption and the increased chance of a false negative result, demand for molecular diagnostics increased.

Molecular diagnostics techniques allow rapid detection of the pathogen involved in sepsis. Furthermore, advancements in nucleic acid extraction and amplification would further assist the growth of the molecular diagnostics segment globally. Technological advancements in molecular diagnostics—higher sensitivity, specificity, and ability to detect fastidious or slow-growing organisms—reduced inhibitory effects of antibiotics and a lesser turnaround time—would drive the growth of the molecular diagnostics market during the forecast period. On the other hand, some factors, such as the risk of false positive results due to the presence of contamination, the lack of a reference standard for the laboratory standardization process, and the unfeasibility of recovering a live bacterial strain for additional diagnostic tests may negatively impact the growth of the molecular diagnostics segment.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

For the purpose of this study, the global sepsis diagnostics market is categorized into three segments:

North America

United States
Canada

Europe

U.K.
Germany
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America

Brazil
Mexico
rest of Latin America

Middle East and Africa

GCC
Rest of the Middle East and Africa

According to the Centers for Disease Control and Prevention (CDC), one in every three patients who die in hospitals has sepsis. As reported in the JAMA study, 1.7 million hospitalizations and 270,000 deaths in the United States alone were attributed to sepsis. The United States is the largest market for sepsis diagnostics. The dominance of the United States and, therefore, the North American market is due to the phenomenal incidence of sepsis in hospitalization, high costs, and eminently high risk of mortality, thus prompting the need for early diagnosis. On the other hand, countries such as India, China, the Philippines, and Australia will collectively render rapid growth to the Asia-Pacific sepsis diagnostics market. The rapid growth of the healthcare system, growing ease in the availability of novel diagnostic and screening methods, and a perpetual rise in the incidence of sepsis

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Sepsis Diagnostics Market Portraiture
2.1.1. Global Sepsis Diagnostics Market, by Product, 2016
2.1.2. Global Sepsis Diagnostics Market, by Technology, 2016
2.1.3. Global Sepsis Diagnostics Market, by Geography, 2016

Chapter 3. Sepsis Diagnostics: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition, by Product, 2016
4.3. Blood Culture Media
4.4. Assay Kits and Reagents
4.5. Instruments

Chapter 5. Global Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition, by Technology, 2016
5.3. Microbiology
5.4. Molecular Diagnostics
5.5. Immunoassays
5.6. Flow Cytometry

Chapter 6. Global Sepsis Diagnostics Market, by Geography, 2015 – 2025
6.1. Overview
6.2. North America Sepsis Diagnostics Market Analysis, 2015 – 2025
6.2.1. North America Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.2.2. North America Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.2.3. North America Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Sepsis Diagnostics Market Analysis, 2015 – 2025
6.3.1. Europe Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.3.2. Europe Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.3.3. Europe Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Sepsis Diagnostics Market Analysis , 2015 – 2025
6.4.1. Asia Pacific Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of APAC
6.5. Latin America Sepsis Diagnostics Market Analysis , 2015 – 2025
6.5.1. Latin America Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Sepsis Diagnostics Market Analysis, 2015 – 2025
6.6.1. MEA Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.6.2. MEA Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.6.3. MEA Sepsis Diagnostics Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Becton, Dickinson and Company
7.3. Biomerieux, Inc.
7.4. Bruker Corporation
7.5. Cepheid, Inc.
7.6. Immunexpress, Inc.
7.7. Nanosphere, Inc. (A Luminex Company)
7.8. Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
7.9. T2 Biosystems, Inc.
7.10. Thermo Fisher Scientific, Inc.

List of Figures

FIG. 1 Sepsis Diagnostics: Market Segmentation
FIG. 2 Global Sepsis Diagnostics Market, by Product, 2016 (US$ Mn)
FIG. 3 Global Sepsis Diagnostics Market, by Technology, 2016 (US$ Mn)
FIG. 4 Global Sepsis Diagnostics Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Blood Culture Media Market in Sepsis Diagnostics, 2015 – 2025 (US$ Mn)
FIG. 8 Global Assay Kits and Reagents Market in Sepsis Diagnostics, 2015 – 2025 (US$ Mn)
FIG. 9 Global Instruments Market in Sepsis Diagnostics, 2015 – 2025 (US$ Mn)
FIG. 10 Global Microbiology Based Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Molecular Diagnostics Microbiology Based Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Immunoassay Microbiology Based Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Flow Cytometry Microbiology Based Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 14 U.S. Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 15 Canada Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 16 U.K. Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 17 Germany Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest of Europe Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 21 Rest of Asia Pacific Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Brazil Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 23 Mexico Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 24 Rest of Latin America Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 25 GCC Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 26 Rest of Middle East and Africa Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 3 North America Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 4 North America Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 5 North America Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Asia Pacific Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Latin America Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Middle East and Africa Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 16 Middle East and Africa Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 Abbott Laboratories Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Becton, Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Biomerieux, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Bruker Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Cepheid, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Immunexpress, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Nanosphere, Inc. (A Luminex Company): Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.) : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 T2 Biosystems, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Questions

What is the size of Sepsis Diagnostics Market?

The market for Sepsis Diagnostics Market is expected to reach US$ 764.2 Bn By 2025.

What is the Sepsis Diagnostics Market CAGR?

The Sepsis Diagnostics Market is expected to see significant CAGR growth over the coming years, at 7.6%.

What is the Forecast period considered for Sepsis Diagnostics Market?

The report is forecasted from 2017-2025.

What is the base year considered for Sepsis Diagnostics Market?

The base year of this report is 2016.

Who are the major players in this market?

Thermo Fisher Scientific, Roche Diagnostics, T2 Biosystems, Bruker Corporation are some of the major players in the global market.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –